Overview of Alopecia Areata

Journal of Investigative Dermatology Symposium Proceedings

Volumn 16, Issue 1, 2013, Pages S13-S15

  Hordinsky, Maria K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE;

ALOPECIA AREATA; GENETICS; HAIR FOLLICLE; HUMAN; IMMUNOLOGY; INNERVATION; METABOLISM; REVIEW;

ALOPECIA AREATA; HAIR FOLLICLE; HUMANS; NEUROPEPTIDES;

MLCS; MLOWN;

EID: 84907227507     PISSN: 10870024     EISSN: 15291774     Source Type: Journal    
DOI: 10.1038/jidsymp.2013.4     Document Type: Review

References (23)

1. Al-Mutairi, N., 308-Nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol 26 (2009), 547–550.
2. Alkhalifah, A., Alsantali, A., Wang, E., et al. Alopecia areata update. J Am Acad Dermatol 62 (2010), 191–202.
3. Blaumeiser, B., van der Goot, I., Fimmers, R., et al. Familial aggregation of alopecia areata. J Am Acad Dermatol 54 (2006), 627–632.
4. Cutter, F.M., Pittelkow, M.R., Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to botulinum A toxin injection. Cephalalgia 26 (2006), 747–751.
5. Delamere, F.M., Sladden, M.J., Dobbins, H.M., et al. Interventions for alopecia areata. Cochrane Database of Systemic Reviews, 2, 2008, CD0 04413 doi: 101002/14651858.CD004413.pub2.
6. Duvic, M., Norris, D., Christiano, A., et al. Alopecia areata registry: an overview. J Invest Dermatol 8 (2003), 219–221.
7. Faghihi, G., Andalib, F., Asilian, A., The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows. Eur J Dermatol 19 (2009), 586–587.
8. Forstbaurer, L.M., Brockschmidt, F.F., Moskvina, V., et al. Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. Eur J Hum Gen 20 (2012), 326–332.
9. Gilhar, A., Ullmann, Y., Berkutzki, T., et al. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101 (1998), 62–67.
10. Gilhar, A., Etzioni, A., Paus, R., Alopecia areata. N Engl J Med 366 (2012), 1515–1525.
11. Gilhar, A., Keren, A., Shemer, A., et al. Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata. J Invest Dermatol, 10, 2012, 1038.
12. Hordinsky, M.K., Kennedy, W., Wendelschafer-Crabb, G., et al. Structure and function of cutaneous nerves in alopecia areata. J Invest Dermatol 104 (1995), 28S–29S.
13. Hordinsky, M., Treatment of alopecia areata. “What is new on the horizon?”. Dermatol Ther 24 (2011), 364–368.
14. Ito, N., Saatoff, M., Hashizume, H., et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 128 (2008), 1196–1206.
15. Ito, T., Hashizume, H., Shimauchi, T., et al. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase. J Dermatol Sci 12 (2012), 944–949.
16. Jagielska, D.D., Redler, S.S., Brockschmidt, F.F., et al. Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J Invest Dermatol 132 (2012), 2192–2197.
17. Kang, H., Wu, W., Lo, B., et al. Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol 130 (2010), 2677–2680.
18. Ochoa, B.E., Sah, D., Wang, G., et al. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata. J Am Acad Dermatol 61 (2009), 530–532.
19. Olsen, E., Hordinsky, M., McDonald-Hull, S., et al. Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 40 (1999), 242–246.
20. Peters, E.M.J., Ericson, M., Hosi, J., et al. Neuropeptide control mechanisms in cutaneous biopsy: physiological mechanisms and clinical significance. Invest Dermatol 126 (2006), 1937–1947.
21. Petukhova, L., Duvic, M., Hordinsky, M., et al. Genome-wide association implicates T-cell and NK-cell activation pathways in alopecia areata. Nature 466 (2010), 113–117.
22. Rodriguez, T.A., Fernandes, K.E., Dresser, K.L., et al. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol 62 (2010), 525–527.
23. Siebenhaar, F., Sharov, A.A., Peters, E.M.J., et al. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol 127 (2007), 1489–1497.